Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    ASLAN004

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASLAN's Enrolls First Patient in Proof-of-Concept Study for ASLAN004
    ASLAN's Enrolls First Patient in Proof-of-Concept Study for ASLAN004

    21 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/aslan-pharmaceuticals-enrolls-first-patient-in-proof-of-concept-study-for-aslan004-targeting-atopic-dermatitis/

    BIOSPACE
    21 Oct 2019
    Share Share
    Aslan retools CSL deal, taking control of would-be Dupixent rival
    Aslan retools CSL deal, taking control of would-be Dupixent rival

    03 Jun 2019

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aslan-retools-csl-deal-taking-control-would-be-dupixent-rival

    Nick Paul Taylor FIERCE BIOTECH
    03 Jun 2019
    Share Share
    Aslan Pharmaceuticals Acquires Full Global Commercial Rights For Aslan004
    Aslan Pharmaceuticals Acquires Full Global Commercial Rights For Aslan004

    01 Jun 2019

    // BIOSPACE

    https://www.biospace.com/article/aslan-pharmaceuticals-acquires-full-global-commercial-rights-for-aslan004-from-csl/?s=79

    BIOSPACE
    01 Jun 2019
    Share Share